Optimal Anti-Tachycardia Therapy in Implantable Cardioverter-Defibrillator Patients Without Pacing Indications | Clinical Trial - OPTION

Description:

The goal of the trial was to evaluate treatment with a dual-chamber defibrillator compared with a single-chamber defibrillator among participants with a primary or secondary indication for an implantable cardioverter-defibrillator (ICD) and left ventricular ejection fraction (LVEF) ≤40%.